— HEXO Corp (“HEXO”, or the “Company”) (TSX: HEXO; NYSE: HEXO) is proud to launch its line of vape products to both adult-use and medical consumers, across Canada. “At HEXO, we pride ourselves in ensuring our consumers have access to high-quality, reliable and consistent cannabis products,” said Sebastien St. Louis, CEO and co-founder of HEXOContinue reading “HEXO vapes now available across Canada”
Tag Archives: Investing in Hexo
HEXO launches medical cannabis products in Israel
— HEXO Corp (TSX: HEXO; NYSE: HEXO) (“HEXO” or the “Company”) is proud to announce that it has launched medical cannabis products in Israel through a 24-month agreement with leading Israeli medical cannabis company, Breath of Life International Ltd. (“BOL”). “For the first time, HEXO’s high-quality medical cannabis is available to medical patients outside of Canada,”Continue reading “HEXO launches medical cannabis products in Israel”
HEXO Corp. Announces Final Closing of Early Conversion Option for Debentures
— HEXO Corp. (“HEXO”, or the “Company”) (TSX: HEXO; NYSE: HEXO) today announced the final closing of its previously announced early conversion option (the “Early Conversion Option”) in respect of $29.86 million aggregate principal amount of its outstanding $70 million aggregate principal amount of 8% unsecured convertible debentures maturing December 5, 2022 (the “Debentures”). UnderContinue reading “HEXO Corp. Announces Final Closing of Early Conversion Option for Debentures”
HEXO Corp. Announces the Sale of its Niagara Facility
OTTAWA, June 17, 2020 (GLOBE NEWSWIRE) — HEXO Corp. (“HEXO”, or the “Company”) (TSX: HEXO; NYSE: HEXO) today announced that it completed the previously disclosed sale of its Niagara, Ontario facility for proceeds of approximately $10.25 million on June 15, 2020. The Company had determined to market the facility for sale following a strategic reviewContinue reading “HEXO Corp. Announces the Sale of its Niagara Facility”
HEXO Corp. Announces C$34,500,000 At-the-Market Offering Program
— HEXO Corp. (“HEXO”, or the “Company”) (TSX: HEXO; NYSE: HEXO) today announced that it has established an at-the-market equity program (the “ATM Program”) that allows the Company to issue up to C$34,500,000 (or its U.S. dollar equivalent) of common shares (the “Common Shares”) from treasury to the public from time to time, at theContinue reading “HEXO Corp. Announces C$34,500,000 At-the-Market Offering Program”
HEXO Corp. reports third quarter fiscal 2020 financial results; Net Revenue Up 30% to $22.1 Million, Improved Operational Performance
Key Operating Highlights Gross Revenue increased 30% to $30.9M from $23.8M in Q2 Net Revenue increased 30% to $22.1M from $17.0M in Q2 Adult-use grams and gram equivalents sold increased 42% to 9,338 kg compared to Q2 Gross Margins increased to 40% Operating expenses decreased to $26.8M Closed $46M public offering to enhance liquidity AdjustedContinue reading “HEXO Corp. reports third quarter fiscal 2020 financial results; Net Revenue Up 30% to $22.1 Million, Improved Operational Performance”
HEXO launches new Tsunami 30 g flower format exclusively to medical clients
OTTAWA, June 03, 2020 (GLOBE NEWSWIRE) — HEXO Corp (“HEXO”, or the “Company”) (TSX: HEXO; NYSE: HEXO) is proud to launch new 30 gram medical flower format for its popular high-THC strain Tsunami under HEXO medical cannabis. HEXO has been dedicated to providing Canadian clients high quality medical cannabis since 2015. A year ago, theContinue reading “HEXO launches new Tsunami 30 g flower format exclusively to medical clients”
